In 2009, the disinfectant and antiseptic market was worth around $3.4 billion, but by 2010 had grown more than 12 percent to reach a value of $3.8 billion, according to a new report from research firm CompaniesAndMarkets.com. Market growth has accelerated in recent years following large-scale outbreaks of avian and swine influenza as well as the presence of methicillin-resistant Staphylococcus aureus (MRSA). The market is expected to rise at a compound annual growth rate (CAGR) of 11.1 percent and reach $7.1 billion by 2016.
The United States constituted approximately 41 percent of the total antiseptics and disinfectants market in 2010 and was around $1.5 billion. The U.S. market is expected to increase to nearly $2.9 billion by 2016 at a CAGR of 11 percent. Europe contributed to about 34 percent of the total market and was $1.3 billion in 2010 and has reached $1.4 billion in 2011. The European market is expected to grow at a CAGR of 11.2 percent and reach $2.4 billion by 2016.
The last decade has seen a rise in the incidence of infectious diseases, and recent outbreaks of swine flu and avian flu have triggered market growth for disinfectants and antiseptic products. These occurrences have heightened public understanding of the serious potential dangers of infection, and the global media coverage which accompanied these incidents has also amplified awareness.